product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Human anti ErbB2 (Trastuzumab Biosimilar)
catalog :
MCA6092
quantity :
0.2 mg
price :
632 USD
clonality :
monoclonal
host :
human
conjugate :
nonconjugated
clone name :
4D5-8
application :
ELISA
more info or order :
citations: 1
Reference
He W, Evans A, Hynes W, Coleman M, Robertson C. Nanolipoprotein-Mediated Her2 Protein Transfection Induces Malignant Transformation in Human Breast Acinar Cultures. ACS Omega. 2021;6:29416-29423 pubmed publisher
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA6092
Description :
Human anti ErbB2 (Trastuzumab Biosimilar)
Specificity :
ErbB2
TargetSpecies :
Human
Host :
Human
Format :
Purified
Isotypes :
IgG1
Applications :
E
ApplicationTypes :
ELISA
Clone :
4D5-8
Quantity :
0.2 mg
QuantityValue :
0.2
QuantityType :
mg
EntityFormats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0 mg/ml
ProductForm :
Human IgG1 (kappa) antibody - liquid
PriceGBP :
441
PriceEUR :
616
PriceUSD :
632 USD
PriceCHF :
670
PriceSEK :
6868
PriceNOK :
7084
PriceDKK :
4595
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.